(Reuters) – A major British trial will investigate U.S. drugmaker Pfizer’s oral COVID-19 treatment as a potential treatment for patients hospitalised with the illness, scientists said on Monday.
The world’s largest randomised study of potential medicines for COVID-19, dubbed the RECOVERY trial, will investigate Paxlovid which has been already approved in Britain for early-stage treatment of coronavirus infections.
(Reporting by Shanima A in Bengaluru; Editing by Amy Caren Daniel)
